RxDoctor Payments Data

Faisal Merchant, MD

Clinical Cardiac Electrophysiology · Atlanta, GANPI 1336130699

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (34.9%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Abbott accounts for 73.9% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $7,043, more than ten times the $622 reported in 2019. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in GA, where the typical reported total is $21,716.

$12,125in general payments, 2019–2025

Across 74 payments — averaging $163.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$9K
  • Boston Scientific$2K
  • Medtronic$698
  • ZOLL Respicardia, Inc.$277
  • Biosense Webster, Inc.$73
$202,621in research payments, 2019–2025

Across 48 payments — averaging $4221.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$175K
  • Medtronic$28K

What the payments were for

  • Speaking & faculty fees$4,02533%
  • Travel & lodging$4,23535%
  • Food & beverage$3,86532%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott46$8,965
Boston Scientific17$2,112
Medtronic(2 entities)9$698
ZOLL Respicardia, Inc.1$277
Biosense Webster, Inc.1$73

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,125 in reported general payments places this provider in the 35th percentile of 93 clinical cardiac electrophysiology providers in Georgia.

See all clinical cardiac electrophysiology providers in Georgia

Medicare billing

Part B allowed, 2024
$220,438
Medicare patients
1,267
Services billed
2,674

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban199$212,711
XareltoRivaroxaban80$96,256
EntrestoSacubitril/Valsartan17$21,842
SotalolSotalol Hcl212$3,830
Flecainide Acetate73$3,673
Propafenone Hcl ErPropafenone Hcl14$2,079
Dofetilide19$2,038
Metoprolol Succinate120$1,558
Amiodarone Hcl48$870
Nadolol16$668
Hydralazine Hcl16$457
Rosuvastatin Calcium12$327
Atorvastatin Calcium36$296
Carvedilol36$286
Spironolactone26$238

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →